Ulcerative colitis Ulcerative colitis
Conditions
Interventions
Elderly patients as the intervention group received 4.3 g (4800 mg) of omega-
3 (4 capsules of 1200 mg) per day for 2 months.,The elderly patients in the control group received placebo (starch) as 500 mg capsules and 4 capsules per day for 2 months and were observed the same wi
Sponsors
Iran University of Medical Sciences
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: All elderly people over 60 years old with mild to moderate ulcerative colitis which were diagnosed with colonoscopy and colon biopsy included in the study
Exclusion criteria
Exclusion criteria: The elderly patients with indeterminate colitis , intestine functional disorder associated with IBD and bacterial infection simultaneously with IBD were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of Inflammatory and oxidative markers Before the treatment and after 2 months of treatment Enzyme-Linked Immunosorbent Assay | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid Profile 12 weeks after treatment TC, LDL-C, TG, HDL-C,Toxicity testing 12 weeks after treatment Blood toxicology (BUN, Creatinine, ALT, ALP, and CBC) | — |
Countries
Iran
Contacts
Public ContactMaryam Biglari Abhari
Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences(IUMS),
Outcome results
None listed